Every SEC Form 3/4/5 on record for this filer (CIK 1801050) — 1 issuer, 159 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | Director | 2020-01-30 → 2026-06-17 | 83 | −$6M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ARQT | 2026-06-17 | Sell | 635 | $25.67 | $16,300 | 37,743 |
| ARQT | 2026-06-15 | Sell | 4,096 | $24.41 | $99,983 | 38,378 |
| ARQT | 2026-05-01 | Sell | 7,144 | $22.99 | $164,241 | 32,600 |
| ARQT | 2026-04-01 | Sell | 10,000 | $23.88 | $238,800 | 39,744 |
| ARQT | 2026-03-02 | Sell | 10,000 | $25.65 | $256,500 | 49,744 |
| ARQT | 2026-02-02 | Sell | 10,000 | $25.05 | $250,500 | 59,744 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.